Natus Medical Buys Alpine Biomed To Expand Neurodiagnostics Portfolio
This article was originally published in The Gray Sheet
Executive Summary
Natus Medical will expand its global presence in the neurology market through its $43.2 million acquisition of neurological disorder diagnostic equipment maker Alpine Biomed, announced Sept. 14
You may also be interested in...
Natus Medical Expands Neurodiagnostics Offerings Via Nicolet Acquisition
CareFusion is divesting its Nicolet neurodiagnostics business, which includes electroencephalography and electromyography devices, for $58 million.
Financings In Brief
Amedica cancels IPO plan: Orthopedic implant maker Amedica cancels plans for an initial public offering, citing adverse stock market conditions in an Aug. 1 statement. The firm says its cash position is "adequate" to continue preparations for a 2008 U.S. market debut of its initial Valeo silicon nitride ceramic spinal implant, and that it will pursue additional financing at an "appropriate" time in the future (1"The Gray Sheet" June 4, 2007, p. 7)...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.